Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition
- 31 July 2004
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 78 (1) , 38-44
- https://doi.org/10.1016/j.athoracsur.2004.02.005
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effect of complement inhibition and heparin coating on artificial surface–induced leukocyte and platelet activationThe Annals of Thoracic Surgery, 2004
- Heparin-coated circuits and reduced systemic anticoagulation applied to 2500 consecutive first-time coronary artery bypass grafting proceduresThe Annals of Thoracic Surgery, 2003
- Inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 2003
- Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypassThe Annals of Thoracic Surgery, 2002
- Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary functionThe Annals of Thoracic Surgery, 2002
- Heparin-coated cardiopulmonary bypass circuits: current statusPerfusion, 2001
- On the blood compatibility of end-point immobilized heparinJournal of Biomaterials Science, Polymer Edition, 2000
- Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary BypassCirculation, 1999
- Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivoThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1998